Jefferies Financial Group
INBX icon

Jefferies Financial Group’s Inhibrx INBX Stock Holding History

Jefferies Financial Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-73,416
Closed -$6.96M – 1546
2026
Q2 		$6.96M Buy
73,416
+34,443
+88% +$3.45M 0.05% 317
2026
Q1 		$2.62M Buy
38,973
+30,072
+338% +$2.23M 0.02% 521
2025
Q4 		$703K Buy
+8,901
New +$606K ﹤0.01% 1233

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Ethic Inc
Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Jefferies Financial Group's INBX Position: Q3 2026 in Review

Jefferies Financial Group sold out of Inhibrx (INBX) in Q3 2026, closing a stake of 73,416 shares — an estimated $6.96M sold.

Jefferies Financial Group first reported a position in INBX in Q4 2025 and held it in 3 quarters. The position peaked at $6.96M in Q2 2026. 50 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Jefferies Financial Group reported no remaining Inhibrx position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 73,416 Inhibrx shares in Q3 2026, an estimated $6.96M.
  • Jefferies Financial Group first reported a position in Inhibrx in Q4 2025 and held it in 3 quarters.
  • Jefferies Financial Group's Inhibrx position peaked at $6.96M in Q2 2026.
  • 50 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.